KyungDong Pharm home
Prescription Medicines

Neuripo HR Tab.

Product Category
Metabolic drugs not separately classified
Active Ingredients
thioctic acid
Appearance
A yellow-green, biconvex, oblong, film-coated tablet.
Reimbursement Code
648103420
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength
1 tablet
- Active ingredient: Thioctic acid (KP) ----- 600mg
- Additives (tar color aluminum lake): Blue No. 1, Blue No. 2, Yellow No. 203
- Other additives: Magnesium stearate, Opadry Green (03B41083), low-substituted hydroxypropyl cellulose, hydroxypropyl cellulose

2. Effectiveness
Relief from diabetic polyneuritis

3. Dosage and dosage
Adults: Take 600 milligrams of thioctic acid once a day, about 30 minutes before breakfast, with plenty of water.

4. Precautions for use
1. Do not administer to the following patients:
1) Patients with hypersensitivity to α-lipoic acid or other excipients
2) This drug is not administered to children and adolescents as there is no clinical experience.

2. Adverse reactions
1) Digestive system: In rare cases, nausea, vomiting, gastrointestinal pain, diarrhea, etc. may occur.
2) Skin: In rare cases, allergic reactions such as skin rash, hives, and itching may occur.
3) In rare cases, blood sugar levels may drop due to increased glucose utilization. In these cases, hypoglycemia-like symptoms such as dizziness, sweating, headache, and visual impairment may appear.
4) In rare cases, taste disorders have been reported.
5) Domestic post-marketing survey results
As a result of a post-marketing use survey conducted on 12,454 people over 4 years for re-examination in Korea, 3 cases of epigastric pain, 2 cases each of vomiting and indigestion, and 1 case each of hives, itching, nausea, abdominal pain, and heartburn.

3. General precautions
Habitual use of alcohol has been observed to be a significant risk factor for the development and progression of neuropathic clinical symptoms and may interfere with the therapeutic effect of this drug. Therefore, patients with diabetic polyneuropathy should avoid alcohol consumption as much as possible, and this also applies to the drug withdrawal period.

4. Interaction
1) Simultaneous administration with this drug may reduce the effect of cisplatin.
2) Do not take α-lipoic acid simultaneously with metal compounds (preparations containing iron and magnesium, milk (containing calcium), etc.) as it forms an insoluble complex in the body. If you take this medication 30 minutes before breakfast, take iron and magnesium supplements at lunch or dinner.
3) Simultaneous administration of this drug may increase the blood sugar-reducing effect of insulin or other oral diabetes drugs, so in such cases, regular monitoring of blood sugar levels is recommended, especially in the early stages of treatment. In some cases, the dosage of insulin or oral diabetes medication may need to be reduced to avoid hypoglycemia.

5. Administration to pregnant and lactating women
1) As a result of reproductive toxicity studies, there was no evidence that this drug affects the fertilization rate or early fetal development, and nothing is clearly known about fetal toxicity.
2) It is not known whether α-lipoic acid is secreted into breast milk.
3) For pregnant and lactating women, the drug should be administered after evaluating its benefits and risks, and should be used when urgently prescribed by a doctor.

6. Treatment in case of overdose
After oral administration of 10-40 g of α-lipoic acid along with alcohol, severe poisoning symptoms, sometimes leading to death, have been observed. Clinical symptoms of poisoning initially appear as restlessness or confusion, and in more serious cases, generalized convulsions and lactic acidosis typically appear. Hypoglycemia, shock, rhabdomyolysis, hemolysis, disseminated intravascular coagulation (DIC), myelosuppression, and multiorgan failure have been reported with high-dose intoxication with α-lipoic acid.
If there is any suspicion of poisoning caused by this drug (more than 10 tablets of 600 mg for adults, or more than 50 mg per kg of body weight for children), the patient should be hospitalized immediately and receive general poisoning treatment. (Vomiting induction, gastrointestinal irrigation, activated charcoal administration, etc.) When treating fatal poisoning states such as generalized nervous system and lactic acidosis, treatment should be conducted according to the principles of intensive treatment and symptomatic treatment. Currently, the benefit of hemodialysis, hemoperfusion, or filtration techniques to promote the excretion of α-lipoic acid has not been established.

7. Storage and handling precautions
1) Do not store above 30℃.
2) Store out of reach of children.
3) Be careful because changing it into another container may cause an accident or is undesirable in terms of maintaining quality.


5. How to save
Airtight container, stored at room temperature (1~30℃)

6. Packaging unit
30 tablets/bottle, 100 tablets/bottle

7. Period of use
36 months from date of manufacture